- Home
- OPT
OPT
Opthea Limited
as 11-15-2024 4:00pm EST
Opthea Ltd operates in one industry being the medical technology and healthcare. It is focused on developing biological therapeutics for eye diseases. The company is developing a novel biologic therapy, OPT-302, for the treatment of eye diseases. Its products are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors C and D and R3 targets. Opthea's development activities are based on an intellectual property portfolio covering key targets Vascular Endothelial Growth Factors VEGF-C, VEGF-D and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage. The company geographically operates Australia and United States.
| Founded: | 1984 | Country: | Australia |
| Employees: | N/A | City: | N/A |
| Market Cap: | 767.9M | IPO Year: | 2020 |
| Target Price: | $12.00 | AVG Volume (30 days): | 39.0K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.35 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.79 - $5.45 | Next Earning Date: | 08-30-2024 |
| Revenue: | $261,859 | Revenue Growth: | -32.03% |
| Revenue Growth (this year): | -32.5% | Revenue Growth (next year): | 46864.64% |
Latest Opthea Limited News
OPT Breaking Stock News: Dive into OPT Ticker-Specific Updates for Smart Investing
GlobeNewswire
2 days ago
Opthea Appoints Kathy Connell to Board of Directors
Simply Wall St.
4 days ago
High Growth Tech Stocks in Australia for November 2024
GlobeNewswire
5 days ago
Opthea’s Wet AMD Program Featured at Ophthalmology Events
GlobeNewswire
13 days ago
Opthea to Participate in November Investor Conferences
Insider Monkey
a month ago
Is Opthea Limited (OPT) the Penny Stock with the Biggest Upside Potential According to Analysts?
GlobeNewswire
a month ago
Opthea Files Notice of Annual General Meeting
GlobeNewswire
a month ago
Opthea Wet AMD Program to be Presented at Innovate Retina
Simply Wall St.
a month ago
High Growth Tech Stocks in Australia to Watch
Compare OPT vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "OPT Opthea Limited - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.